Biotech Showcase

Active

Overview

Biotech Showcase is an annual investor conference for private and micro-mid-cap biotechnology companies to present to investors and biopharmaceutical executives. Held during JPM Week in San Francisco with a hybrid in-person and digital format, it features over 400 presenting companies across therapeutics, platforms, digital health, devices, and diagnostics, attracting investors managing over $400 billion. The event facilitates thousands of one-on-one meetings via the partneringONE platform.

History

Launched in 2008, Biotech Showcase has grown to its 18th edition in 2026. It is co-produced by Demy-Colton and EBD Group, expanding to include family events like Seed Showcase and TechBio Showcase. The conference adopted a hybrid format post-2020 and consistently draws global participants during San Francisco's JPM Week.

Product Lines

Product Line	Positioning	Price Range
In-Person Conference Pass	On-site access to presentations and networking	$2,000 - $4,000
Digital Partnering Pass	Virtual one-on-one meetings platform	$1,500 - $3,000
Presenting Company Slot	Investor pitch presentation opportunity	$10,000 - $20,000
Seed Showcase Track	Early-stage startup presentations	$5,000 - $12,000
TechBio Showcase Track	Technology-enabled biotech focus	$8,000 - $15,000

Manufacturing

As an event organizer, Biotech Showcase does not manufacture physical products; all activities are service-based, with in-person events hosted at Hilton San Francisco Union Square and digital components on the partneringONE platform.

Notable Products

Biotech Showcase Main Conference - Core annual event January 12-14, 2026, with 400+ company presentations and investor meetings.
partneringONE Digital Platform - Virtual partnering system used January 20-21, 2026, for post-event meetings.
Seed Showcase - Dedicated track for seed-stage biotech startups within the main event.
TechBio Showcase - Track highlighting technology-driven biotech innovations.

Reputation

Biotech Showcase is regarded as a key venue for biotech fundraising during JPM Week, valued for high investor attendance and deal facilitation. Professionals note its role in securing over $20 billion in deals from 2023-2025 presentations. Some criticism focuses on high participation costs and competitive selection process limiting access for smaller firms.

Sources (9)